The effectiveness of trimetazidine and fabomotizole in the prevention of angina progression and improvement of life quality in patients in area of armed conflict

The effectiveness of trimetazidine and fabomotizole in the prevention of angina progression and improvement of life quality in patients in area of armed conflict

Aim. To assess the effectiveness of trimetazidine and fabomotizole adding to standard treatment in prevention of stable angina progression and improving of quality of life (QOL) in patients in area of armed conflict.Material and methods. One hundred and twelve patients with stable angina of II-III f...

Full description

Saved in:

Bibliographic Details
Main Authors:	Z. Yu. Shakhbiyeva, A. A. Abdullaev, U. A. Isiamova, D. D. Abdulpatakhov, A. A. Abdullaeva
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2019-03-01
Series:	Российский кардиологический журнал
Subjects:	trimetazidine fabomotizole quality of life stable angina
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/3137
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effectiveness of the original trimetazidine MR in patients with stable coronary heart disease and angina attacks resistant to trimetazidine generics (ETALON study)
by: A. V. Fendrikova, et al.
Published: (2011-08-01)

Results of Holter monitoring in patients with angina pectoris treated by combination of trimethazidine with fabomotisol in the area of former armed conflict
by: Z. Yu. Shakhbieva, et al.
Published: (2019-06-01)

Efficacy of Trimetazidine and Sulodexide in Patients with Microvascular Angina
by: S. A. Boldueva, et al.
Published: (2020-07-01)

Carbohydrate metabolism parameters in angina patients treated with metoprolol and its combination with trimetazidine
by: E. V. Bochkareva, et al.
Published: (2012-08-01)

Comparing effectiveness of adding prolonged trimetazidine or isosorbide dinitrate to beta-adrenoblocker therapy in stable angina patients
by: M. G. Glezer, et al.
Published: (2006-08-01)

CLINICAL EFFECTIVENESS OF THE MODIFIED RELEASE TRIMETAZIDINE IN MICROVASCULAR ANGINA
by: P. Yu. Galin, et al.
Published: (2016-12-01)

Anti-anginal and anti-ischemic effectiveness of trimetazidine MB in patients with unstable angina
by: M. G. Glezer, et al.
Published: (2009-02-01)

Effectiveness and Tolerability of Trimetazidine 80 mg Once Daily in Patients with Chronic Coronary Syndrome in Brazil: The V-GOOD Observational Study
by: Luís Henrique Wolff Gowdak, et al.
Published: (2025-04-01)

The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label use
by: O. V. Tsygankova, et al.
Published: (2019-12-01)

Pharmacological treatment of stable angina pectoris: the place of trimetazidine
by: E. A. Temnikova
Published: (2022-12-01)

Effects of Trimetazidine Combined with Atorvastatin on Cardiac Function in Patients with Stable Angina Pectoris of Coronary Heart Disease
by: Zhang N, et al.
Published: (2025-04-01)

New potential of Trimetazidine MB for coronary heart disease treatment in the real-world clinical practice: results of the Russian multi-centre randomised study PERSPECTIVE (Part II)
by: M. G. Bubnova, et al.
Published: (2011-12-01)

TRIMETAZIDINE THERAPY INFLUENCE ON HEART RATE VARIABILITY IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
by: M. V. Novikova, et al.
Published: (2014-10-01)

CARDIOPROTECTION POTENTIAL IN CORONARY HEART DISEASE TREATMENT
by: N. A. Shostak, et al.
Published: (2009-12-01)

Pleiotropic effects of trimetazidine
by: O. V. Romashchenko, et al.
Published: (2013-08-01)

Dna damage in myocardial cells of rats with experimental alcoholic cardiomyopathy: modifyng effects of fabomotizole and trimetazidene
by: A. K. Zhanataev, et al.
Published: (2018-03-01)

Trimetazidine in coronary heart disease patients: mechanism of action and controlled trials’ results
by: L. V. Kremneva, et al.
Published: (2005-04-01)

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015-12-01)

Comparative study of the trimetazidine and fabomotizole hydrochloride сardioprotective effect in rats with established alcoholic cardiomyopathy with the continued ethanol consumption
by: I. B. Tsorin, et al.
Published: (2016-09-01)

The effect of fabomotizole on blood microcirculation in intact and ischemic myocardium
by: I. B. Tsorin, et al.
Published: (2022-07-01)

Investigation of the fabomotizol dihydrochloride effect on the morphological picture of the heart left ventricle in rats with the subacute myocardial infarction
by: I. A. Miroshkina, et al.
Published: (2022-02-01)

TRIMETAZIDINE INFLUENCE ON FILTRATION AND TUBULOINTERSTITIAL FUNCTION OF KIDNEYS IN ISCHEMIC HEART DISEASE PATIENTS WITH CHRONIC HEART FAILURE AND RENAL DYSFUNCTION
by: N. A. Koziolova, et al.
Published: (2018-03-01)

Clinical characteristics and management of post-myocardial infarction patients with stable angina in the outpatient practice of Ukrainian cardiologists (GO-OD study)
by: O. M. Parkhomenko, et al.
Published: (2025-02-01)

ENDOTHELIAL DYSFUNCTION AND ITS CORRECTION WIT CYTOPROTECTORS IN PATIENTS WITH STABLE EFFORT ANGINA AND ARTERIAL HYPERTENSION
by: F. E. Khlebodarov, et al.
Published: (2009-12-01)

Combined effect of fabomotizol and the compound ALM-802 on atrial depolarization in a translational model of alcoholic cardiomyopathy in rats
by: S. L. Smirnova, et al.
Published: (2023-07-01)

Effect of the anxiolytic fabomotizol on the time parameters of atrial depolarization in the acute phase of myocardial infarction
by: S. L. Smirnova, et al.
Published: (2023-01-01)

Study of fabomotizole effect on the behavioral disorders in rat offsprigs exposed to tabaco smoke and ethanol
by: A. S. Solomina, et al.
Published: (2018-03-01)

MANAGEMENT OF ANGINA ATTACKS IN HEART FAILURE DUE TO NONCORONARY HEART DISEASE: TRIMETAZIDINE USAGE
by: M. Yu. Sitnikova, et al.
Published: (2015-11-01)

Gender, age and morphofunctional characteristics of the quality of life of patients with stable angina
by: V. K. Tashchuk, et al.
Published: (2023-03-01)

TRIMETAZIDINE MR EFFECTS ON THE PARAMETERS OF 24-HOUR ELECTROCARDIOGRAM MONITORING AND HEART RATE VARIABILITY
by: M. V. Novikova, et al.
Published: (2013-10-01)

TRIMETAZIDINE MB ROLE IN THE OPTIMISATION OF THE ACUTE CORONARY SYNDROME TREATMENT: EFFECTS ON ENDOTHELIAL DYSFUNCTION AND SYSTEMIC INFLAMMATION
by: S. I. Davydov, et al.
Published: (2013-12-01)

The efficacy and safety of coronary sinus reducer in refractory angina: a systematic review and meta-analysis
by: Ahmed Elshahat, et al.
Published: (2025-07-01)

THE USAGE OF TRIMETAZIDINE AND SULODEXIL TO PREVENT TRANSFORMATION OF A NON-Q MI INTO A Q-MI
by: A. A. Abdullaev, et al.
Published: (2001-10-01)

On the mechanism of the antiarrhythmic action of fabomotizole hydrochloride in alcoholic cardiomyopathy
by: I. A. Miroshkina, et al.
Published: (2021-09-01)

The study of antiparkinsonian activity of the combination of ladasten with fabomotizole in paraquat-induced model of parkinsoian syndrome
by: V. E. Marievskii, et al.
Published: (2025-05-01)

Effectiveness of a selective If channel inhibitor ivabradine in patients with stable angina
by: E. V. Kuleshova
Published: (2009-10-01)

Stable angina diagnostics and treatment in elderly patients
by: V. P. Lupanov, et al.
Published: (2008-10-01)

Secondary prevention effectiveness in patients with stable angina
by: Rasim Kutlu, et al.
Published: (2010-08-01)

CYTOPROTECTION WITH TRIMETAZIDINE MB: RECENT DATA
by: I. G. Gordeev, et al.
Published: (2015-05-01)

Trimetazidine effects on mitochondria energetic activity
by: S. V. Eliseeva, et al.
Published: (2008-12-01)